Page 105 - Read Online

Page 235 Xu et al. J Transl Genet Genom 2021;5:218-39 https://dx.doi.org/10.20517/jtgg.2021.20

73. Rytting ME, Thomas DA, O'Brien SM, et al. Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs)
with acute lymphoblastic leukemia (ALL). Cancer 2014;120:3660-8. DOI PubMed PMC
74. Stock W, Luger SM, Advani AS, et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic
leukemia (ALL): early results of U.S. intergroup trial C10403. Blood 2014;124:796. DOI
75. DeAngelo DJ, Stevenson KE, Dahlberg SE, et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50
years with newly diagnosed acute lymphoblastic leukemia. Leukemia 2015;29:526-34. DOI PubMed PMC
76. Rytting ME, Jabbour EJ, Jorgensen JL, et al. Final results of a single institution experience with a pediatric-based regimen, the
augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the
hyper-CVAD regimen. Am J Hematol 2016;91:819-23. DOI PubMed PMC
77. Sive JI, Buck G, Fielding A, et al. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international
MRC UKALL XII/ECOG2993 trial. Br J Haematol 2012;157:463-71. DOI PubMed PMC
78. Pulte D, Jansen L, Gondos A, et al; GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in
Germany and the United States. PLoS One 2014;9:e85554. DOI PubMed PMC
79. Bailey C, Richardson LC, Allemani C, et al; CONCORD Working Group (US members). Adult leukemia survival trends in the
United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009. Cancer
2018;124:3856-67. DOI PubMed PMC
80. Huguet F, Chevret S, Leguay T, et al; Group of Research on Adult ALL (GRAALL). Intensified therapy of acute lymphoblastic
leukemia in adults: report of the randomized GRAALL-2005 clinical trial. J Clin Oncol 2018;36:2514-23. DOI PubMed
81. O'Dwyer KM, Liesveld JL. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment
and novel therapies. Best Pract Res Clin Haematol 2017;30:184-92. DOI PubMed
82. Luskin MR, Deangelo DJ. Mini-Hyper-CVD combinations for older adults: results of recent trials and a glimpse into the future. Clin
Lymphoma Myeloma Leuk 2020;20:S44-7. DOI PubMed
83. Wang L, Bhatia S, Gomez SL, Yasui Y. Differential inequality trends over time in survival among U.S. children with acute
lymphoblastic leukemia by race/ethnicity, age at diagnosis, and sex. Cancer Epidemiol Biomarkers Prev 2015;24:1781-8. DOI
PubMed PMC
84. Goggins WB, Lo FF. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the
SEER database 1988-2008. Cancer Causes Control 2012;23:737-43. DOI PubMed
85. Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD. Racial disparities in the survival of American children, adolescents,
and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma. Cancer 2016;122:2723-
30. DOI PubMed PMC
86. Kahn JM, Cole PD, Blonquist TM, et al. An investigation of toxicities and survival in Hispanic children and adolescents with ALL:
results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001. Pediatr Blood Cancer 2018;65:e26871. DOI
PubMed PMC
87. Abrahão R, Lichtensztajn DY, Ribeiro RC, et al. Racial/ethnic and socioeconomic disparities in survival among children with acute
lymphoblastic leukemia in California, 1988-2011: A population-based observational study. Pediatr Blood Cancer 2015;62:1819-25.
DOI PubMed
88. Murphy CC, Lupo PJ, Roth ME, Winick NJ, Pruitt SL. Disparities in cancer survival among adolescents and young adults: a
population-based study of 88,000 patients. J Natl Cancer Inst ;2021:djab006. DOI PubMed
89. Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M. Recent trends in survival of adult patients with acute leukemia: overall
improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica
2013;98:222-9. DOI PubMed PMC
90. Quiroz E, Aldoss I, Pullarkat V, Rego E, Marcucci G, Douer D. The emerging story of acute lymphoblastic leukemia among the Latin
American population - biological and clinical implications. Blood Rev 2019;33:98-105. DOI PubMed
91. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City:
descriptive epidemiology. BMC Cancer 2011;11:355. DOI PubMed PMC
92. Santamaría-Quesada C, Vargas M, Venegas P, et al. Molecular and epidemiologic findings of childhood acute leukemia in Costa
Rica. J Pediatr Hematol Oncol 2009;31:131-5. DOI PubMed
93. Moore KJ, Hubbard AK, Williams LA, Spector LG. Childhood cancer incidence among specific Asian and Pacific Islander
populations in the United States. Int J Cancer 2020;147:3339-48. DOI PubMed PMC
94. Shah N, Rockwell B, Kazemi M, et al. Ethnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era - a
SEER analysis. Leuk Lymphoma 2020;61:3503-6. DOI PubMed
95. Chiaretti S, Messina M, Della Starza I, et al. Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual
disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. Haematologica
2021;106:1559-68. DOI PubMed PMC
96. Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med
2014;371:1005-15. DOI PubMed PMC
97. Herold T, Baldus CD, Gökbuget N. Ph-like acute lymphoblastic leukemia in older adults. N Engl J Med 2014;371:2235. DOI
PubMed
98. Roberts KG, Gu Z, Payne-Turner D, et al. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic
leukemia in adults. J Clin Oncol 2017;35:394-401. DOI PubMed PMC
99. Jain N, Roberts KG, Jabbour E, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 2017;129:572-81.